StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Danaher (DHR) PT Raised to $125 at Baird
February 26, 2019 9:15 AM
Baird analyst Richard Eastman raised the price target on Danaher (NYSE: DHR) to $125.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
Danaher (DHR) PT Raised to $144 at UBS
February 26, 2019 8:10 AM
Danaher (DHR) PT Raised to $130 at Deutsche Bank
February 26, 2019 7:27 AM
Danaher (DHR) Announces Proposed $1.35B Common Share Offering; Announces Concurrent $1.35B Mandatory Convertible Preferred Share Offering
February 26, 2019 5:45 AM
Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock
February 25, 2019 5:12 PM
Danaher (DHR) March 125 calls active after acquiring the biopharma business of GE Life Sciences
February 25, 2019 9:56 AM
Janney Upgrades Danaher (DHR) to Buy
February 25, 2019 9:32 AM
Pre-Open Stock Movers 02/25: (ONCE) (CMTA) (QURE) Higher; (MDR) (CRON) (NBR) Lower (more...)
February 25, 2019 9:25 AM
General Electric (GE) to Sell BioPharma Business to Danaher (DHR) for $21.4 Billion
February 25, 2019 7:00 AM
Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion
February 25, 2019 7:00 AM
GE to Sell BioPharma Business to Danaher for $21.4 Billion
February 25, 2019 7:00 AM
